TN2013000074A1 - Fused triazoles for the treatment or prophylaxis of mild cognitive impairment - Google Patents

Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Info

Publication number
TN2013000074A1
TN2013000074A1 TNP2013000074A TN2013000074A TN2013000074A1 TN 2013000074 A1 TN2013000074 A1 TN 2013000074A1 TN P2013000074 A TNP2013000074 A TN P2013000074A TN 2013000074 A TN2013000074 A TN 2013000074A TN 2013000074 A1 TN2013000074 A1 TN 2013000074A1
Authority
TN
Tunisia
Prior art keywords
prophylaxis
treatment
cognitive impairment
mild cognitive
fused triazoles
Prior art date
Application number
TNP2013000074A
Other languages
French (fr)
Inventor
Makoto Kamata
Tatsuki Koike
Minoru Nakamura
Yoshihide Tomata
Takafumi Takai
Yasutaka Hoashi
Yuichi Kajita
Tetsuya Tsukamoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2011/070419 external-priority patent/WO2012029991A1/en
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2013000074A1 publication Critical patent/TN2013000074A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

he present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and/or a superior γ-secretase modulation activity, and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
TNP2013000074A 2011-09-01 2013-02-22 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment TN2013000074A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/070419 WO2012029991A1 (en) 2010-09-02 2011-09-01 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Publications (1)

Publication Number Publication Date
TN2013000074A1 true TN2013000074A1 (en) 2014-06-25

Family

ID=54360770

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000074A TN2013000074A1 (en) 2011-09-01 2013-02-22 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Country Status (1)

Country Link
TN (1) TN2013000074A1 (en)

Similar Documents

Publication Publication Date Title
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
PH12016501614A1 (en) Heterocyclic compound
PH12016501582A1 (en) Fused heterocyclic compound
PH12015502549B1 (en) Heterocyclic derivatives
MX2013002511A (en) Fused triazoles for the treatment or prophylaxis of mild cognitive impairment.
PH12014502396B1 (en) Nitrogenated heterocyclic compound
MX2013006113A (en) Bicyclic compound.
WO2012135113A3 (en) Cyclopropylamines as lsd1 inhibitors
MX359032B (en) Pyrrolopyrazine kinase inhibitors.
IN2014CN04558A (en)
PH12015501316A1 (en) Heterocyclic compound
NZ732511A (en) Small molecule inhibitors of egfr and pi3k
MX2014012266A (en) Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents.
MX2013002851A (en) Inhibitors of notum pectinacetylesterase and methods of their use.
PH12017500290A1 (en) Heterobicyclic compounds and their use for the treatment of tuberculosis
MX2014013758A (en) Thiazolecarboxamide derivatives for use as nampt inhibitors.
MX353062B (en) Novel heterocyclic carboxamides as modulators of kinase activity.
MY194015A (en) Sodium channel blocker
AU2016330503A8 (en) Therapeutic compounds and methods of use thereof
TN2013000074A1 (en) Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
IN2012DN02069A (en)
CR20130119A (en) Cast triazoles for the treatment or prophylaxis of mild cognitive impairment
TN2013000230A1 (en) Bicyclic compound
UA109932C2 (en) CYCLOPROPYLAMINS AS LSD1 INHIBITORS
GEP201606554B (en) Nitrogenated heterocyclic compound